Navigation Links
The first laugh: New study posits evolutionary origins of two distinct types of laughter

In an important new study from the forthcoming Quarterly Review of Biology, biologists from Binghamton University explore the evolution of two distinct types of laughter ?laughter which is stimulus-driven and laughter which is self-generated and strategic.

"Laughter that occurs during everyday social interaction in response to banal comments and humorless conversation is now being studied," write Matthew Gervais and David Sloan Wilson. "The unstated issue is whether such laughter is similar in kind to laughter following from humor."

Using empirical evidence from across disciplines, including theory and data from work on mirror neurons, evolutionary psychology, and multilevel selection theory, the researchers detail the evolutionary trajectory of laughter over the last 7 million years. Evolutionarily elaborated from ape play-panting sometime between 4 million years ago and 2 million years ago, laughter arising from non-serious social incongruity promoted community play during fleeting periods of safety. Such non-serious social incongruity, it is argued, is the evolutionary precursor to humor as we know it.

However, neuropsychological and behavioral studies have shown that laughter can be more than just a spontaneous response to such stimuli. Around 2 million years ago, human ancestors evolved the capacity for willful control over facial motor systems. As a result, laughter was co-opted for a number of novel functions, including strategically punctuating conversation, and conveying feelings or ideas such as embarrassment and derision.

"Humans can now voluntarily access the laughter program and utilize it for their own ends, including smoothing conversational interaction, appeasing others, inducing favorable stances in them, or downright laughing at people that are not liked," write Gervais and Wilson.


'"/>

Source:University of Chicago Press Journals


Page: 1

Related biology news :

1. A genes first kiss sets off that affair known as puberty
2. Love at first smell
3. Worlds largest rainforest drying experiment completes first phase
4. PCRM develops worlds first cruelty-free insulin assay
5. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
6. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
7. DuPonts first biologically derived polymer receives global recognition
8. Anti cancer virotherapy well tolerated in first human administration, research finds
9. Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development
10. The first impact factor for PLoS Biology ?13.9
11. Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT

Post Your Comments:
(Date:11/24/2009)...crets of the earth,s history locked in its icy dep...e information on the environments that have been s...Now, a team of researchers from nine institutions ...0 million dollars by the National Science Foundati...lly. These scientists will drill through the West ...
(Date:11/23/2009)... strain of the deadly superbug MRSAan infection-ca...sposes a far greater health threat than previously...ding to a study in the December issue of Emerging...ly picked up in fitness centers, schools, and othe...en of MRSA within hospitals, the report found. , ...
(Date:11/23/2009)...that a common oral bacterium may exacerbate autoim..., "Unique Lipids from a Common Human Bacterium Rep...ncing Autoimmunity," appears in the December 2009 ...Multiple sclerosis (MS), a disease where the immun...s nearly 1 in 700 people in the United States. Pa...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2OAG Releases Prototype for Pandemic Disease Planning and Management 56336 1OAG Releases Prototype for Pandemic Disease Planning and Management 56336 2OAG Releases Prototype for Pandemic Disease Planning and Management 56336 3Restorative Therapies Inc Receives FDA Clearance for RT300 Enhancements 56333 1Restorative Therapies Inc Receives FDA Clearance for RT300 Enhancements 56333 2Restorative Therapies Inc Receives FDA Clearance for RT300 Enhancements 56333 3Making bacteria make useful proteins 13871 1
...essing their children, at least among side-blotche...States. Researchers at the University of Californi...d lizards are able to induce different color patte... "dressing" their progeny in patterns they will we...ence gives her progeny the patterns most likely to...
...n genetic factors and certain adverse events relat...in the July 15th issue of The Journal of Infectiou...tions for predicting adverse events from other liv...ts has been one of the greatest successes of moder...he world is considered by some to be the crowning ...
...finding new drugs to fight MRSA, cancers and other...isation announced that its fungal collection will ...BI houses one of the world’s largest genetic resou...strains, including Fleming’s original penicillin p...ersity of Strathclyde’s Institute for Drug Researc...
Other Biology News:Study shows lizard moms dress their children for success 2Study shows lizard moms dress their children for success 3Study shows lizard moms dress their children for success 4Genetic factors are linked to fever following smallpox vaccination 2Could fungal collection hold the key to new life-saving drugs? 2
(Date:11/24/2009)... The New York investment bank KTA Capital,s cli...d an AU$6.7 mil convertible note private placement...lacement was arranged by KTA Capital as Neuren,s e... New York (PRWEB) November 23, 2009 ...pital, LLC ("KTA Capital") has announced...
(Date:11/24/2009)...IS, Nov. 24 Sigma-Aldric...at the NASDAQ OMX conference on Tuesday, December ...rested parties may listen via live audio broadcast...tor.sig m a a ldrich.com/ . Users can click ...About Sigma-Aldrich: Sigma-Aldrich is a leading ...
(Date:11/24/2009)...TEO, Calif., Nov. 24 Neu... company focused on developing and commercializing...that Anthony DiTonno, President and Chief Executiv...ual Piper Jaffray Health Care Conference, to be he... in New York, New York. ,, Mr. DiTonno and Ste...
(Date:11/24/2009)...ary efficacy endpoint has been met for patients wi...cer, , QUEBEC CITY, Nov. 24 /PRNewswire-First...: AEZ) (the "Company"), a global biopharmaceutical..., today announced positive efficacy data from a Ph...njugate, AEZS-108 (formerly AN-152), in patients w...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...iated a Phase II study of R1507 ...ark, December 20 Genmab A/S,(OMX: GEN) announced ...e II,clinical study of R1507 for the treatment of ...y was created by Genmab under the company,s,agreem...igger a milestone,payment to Genmab of USD 500,000...
... a,drug and diagnostic discovery company, announce... to initiate a Phase 2 clinical trial of its,thera...mer,s disease. EHT,0202 is a compound, with a nove... memory and neuronal loss., This will be the firs...a multi-center, double-blind trial, in which 135 p...
...; Looks to Build Upon 2007 ...scoring its continued commitment,to advancing acce...he Avon,Foundation today announced the 2008 Avon W... in Avon Walk history, the series will expand into...mentum of a record-breaking,2007 Avon Walk season....
Other Biology Technology:Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma 2ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimer's Disease 2ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimer's Disease 3ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimer's Disease 4Avon Foundation Announces 2008 Avon Walk for Breast Cancer Schedule 2Avon Foundation Announces 2008 Avon Walk for Breast Cancer Schedule 3
RABBIT (BABY) COMPLEMENT LYOPHILISED from AbD Serotec
Rabbit Anti-Human ZO-1 Antibody, Unconjugated from Lab Vision
Mouse Anti-Human Myeloid Marker Monoclonal Antibody, Unconjugated, Clone BM-1 from Santa Cruz Biotechnology, Inc.
5x C'GATE STOCK STABILIZING REAGENT from AbD Serotec
Biology Products: